Literature DB >> 4598611

Variables influencing susceptibility testing of Cryptococcus neoformans to 5-fluorocytosine.

E R Block, A E Jennings, J E Bennett.   

Abstract

The minimum inhibitory concentration (MIC) of 5-fluorocytosine (5-FC) was determined for 65 isolates of Cryptococcus neoformans by using a twofold serial tube dilution method. The MIC was profoundly influenced by incubation temperature, inoculum size, and duration of incubation. By using a standard set of test conditions, 100% of 49 pretreatment isolates of C. neoformans were susceptible to 10 mug of 5-FC per ml or less, and 9 (56%) of 16 isolates recovered during or after 5-FC therapy were massively drug resistant (MIC > 320 mug/ml). With the standard test conditions recommended here, the tube dilution method was found to be both accurate and reproducible, and the results correlated with the treatment status of patients.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4598611      PMCID: PMC444565          DOI: 10.1128/AAC.4.4.392

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  5-fluorocytosine in the treatment of mycotic infections.

Authors:  A G Vandevelde; A A Mauceri; J E Johnson
Journal:  Ann Intern Med       Date:  1972-07       Impact factor: 25.391

2.  5-fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience.

Authors:  P L Steer; M I Marks; P D Klite; T C Eickhoff
Journal:  Ann Intern Med       Date:  1972-01       Impact factor: 25.391

3.  Candida at Boston City Hospital. Clinical and epidemiological characteristics and susceptibility to eight antimicrobial agents.

Authors:  P Toala; S A Schroeder; A K Daly; M Finland
Journal:  Arch Intern Med       Date:  1970-12

4.  In vitro susceptibility of Cryptococcus neoformans to amphotericin B, hamycin, and 5-fluorocytosine.

Authors:  S Shadomy; H J Shadomy; J A McCay; J P Utz
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1968

5.  Application of four methods to the study of the susceptibility of yeast to 5-fluorocytosine.

Authors:  M I Marks; T C Eickhoff
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

6.  In vitro studies with 5-fluorocytosine.

Authors:  S Shadomy
Journal:  Appl Microbiol       Date:  1969-06

7.  Further in vitro studies with 5-fluorocytosine.

Authors:  S Shadomy
Journal:  Infect Immun       Date:  1970-10       Impact factor: 3.441

8.  In vitro studies of 5-fluorocytosine resistance in Candida albicans and Torulopsis glabrata.

Authors:  S Normark; J Schönebeck
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191

9.  5-fluorocytosine resistance in Cryptococcus neoformans.

Authors:  E R Block; A E Jennings; J E Bennett
Journal:  Antimicrob Agents Chemother       Date:  1973-06       Impact factor: 5.191

10.  In vitro activity of 5-fluorocytosine against Candida and Torulopsis species.

Authors:  S Shadomy; C B Kirchoff; A E Ingroff
Journal:  Antimicrob Agents Chemother       Date:  1973-01       Impact factor: 5.191

  10 in total
  26 in total

1.  Spectrophotometric method of inoculum preparation for the in vitro susceptibility testing of filamentous fungi.

Authors:  A Espinel-Ingroff; T M Kerkering
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

2.  Combination of amphotericin B with flucytosine is active in vitro against flucytosine-resistant isolates of Cryptococcus neoformans.

Authors:  Patrick Schwarz; Guilhem Janbon; Françoise Dromer; Olivier Lortholary; Eric Dannaoui
Journal:  Antimicrob Agents Chemother       Date:  2006-10-16       Impact factor: 5.191

Review 3.  Antifungal susceptibility tests.

Authors:  J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

4.  Rapid, simple bioassay for 5-fluorocytosine in the presence of amphotericin B.

Authors:  R L Kaspar; D J Drutz
Journal:  Antimicrob Agents Chemother       Date:  1975-04       Impact factor: 5.191

5.  In vitro susceptibilities of yeasts to a new antifungal triazole, SCH 39304: effects of test conditions and relation to in vivo efficacy.

Authors:  K A McIntyre; J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

6.  Effects of temperature on anti-Candida activities of antifungal antibiotics.

Authors:  F C Odds
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

7.  Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts.

Authors:  G V Doern; T A Tubert; K Chapin; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

8.  Turbidimetric studies of growth inhibition of yeasts with three drugs: inquiry into inoculum-dependent susceptibility testing, time of onset of drug effect, and implications for current and newer methods.

Authors:  J N Galgiant; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

9.  Collaborative investigation of variables in susceptibility testing of yeasts.

Authors:  M A Pfaller; M G Rinaldi; J N Galgiani; M S Bartlett; B A Body; A Espinel-Ingroff; R A Fromtling; G S Hall; C E Hughes; F C Odds
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

10.  Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent of inoculum size.

Authors:  J N Galgiani; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.